nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—CYP3A4—Rosuvastatin—atherosclerosis	0.0817	0.211	CbGbCtD
Hydralazine—CYP3A4—Ezetimibe—atherosclerosis	0.0817	0.211	CbGbCtD
Hydralazine—CYP3A4—Simvastatin—atherosclerosis	0.0759	0.196	CbGbCtD
Hydralazine—CYP3A4—Pravastatin—atherosclerosis	0.0743	0.192	CbGbCtD
Hydralazine—CYP3A4—Lovastatin—atherosclerosis	0.0743	0.192	CbGbCtD
Hydralazine—AOC3—endothelium—atherosclerosis	0.0193	0.187	CbGeAlD
Hydralazine—AOC3—blood vessel—atherosclerosis	0.0178	0.172	CbGeAlD
Hydralazine—Polyneuropathy—Simvastatin—atherosclerosis	0.0137	0.0291	CcSEcCtD
Hydralazine—RYR2—cardiovascular system—atherosclerosis	0.0132	0.127	CbGeAlD
Hydralazine—AOC3—connective tissue—atherosclerosis	0.00915	0.0882	CbGeAlD
Hydralazine—AOC3—cardiovascular system—atherosclerosis	0.00796	0.0767	CbGeAlD
Hydralazine—P4HA1—connective tissue—atherosclerosis	0.00731	0.0705	CbGeAlD
Hydralazine—AOC3—adipose tissue—atherosclerosis	0.00702	0.0677	CbGeAlD
Hydralazine—Blood disorder—Rosuvastatin—atherosclerosis	0.00676	0.0143	CcSEcCtD
Hydralazine—Proteinuria—Rosuvastatin—atherosclerosis	0.00643	0.0136	CcSEcCtD
Hydralazine—P4HA1—cardiovascular system—atherosclerosis	0.00636	0.0613	CbGeAlD
Hydralazine—Protein urine present—Rosuvastatin—atherosclerosis	0.00634	0.0134	CcSEcCtD
Hydralazine—Hepatomegaly—Niacin—atherosclerosis	0.00581	0.0123	CcSEcCtD
Hydralazine—P4HA1—adipose tissue—atherosclerosis	0.00561	0.0541	CbGeAlD
Hydralazine—Tingling sensation—Niacin—atherosclerosis	0.00511	0.0108	CcSEcCtD
Hydralazine—Proteinuria—Simvastatin—atherosclerosis	0.0051	0.0108	CcSEcCtD
Hydralazine—Protein urine present—Simvastatin—atherosclerosis	0.00503	0.0106	CcSEcCtD
Hydralazine—AOC3—liver—atherosclerosis	0.00492	0.0475	CbGeAlD
Hydralazine—Vasculitis—Lovastatin—atherosclerosis	0.00491	0.0104	CcSEcCtD
Hydralazine—Numbness—Pravastatin—atherosclerosis	0.00488	0.0103	CcSEcCtD
Hydralazine—Vasculitis—Ezetimibe—atherosclerosis	0.00481	0.0102	CcSEcCtD
Hydralazine—Sensory loss—Pravastatin—atherosclerosis	0.00467	0.00989	CcSEcCtD
Hydralazine—Vasculitis—Simvastatin—atherosclerosis	0.00459	0.00971	CcSEcCtD
Hydralazine—Renal failure acute—Rosuvastatin—atherosclerosis	0.00444	0.0094	CcSEcCtD
Hydralazine—Vasculitis—Pravastatin—atherosclerosis	0.00415	0.00878	CcSEcCtD
Hydralazine—Hepatic function abnormal—Lovastatin—atherosclerosis	0.00398	0.00841	CcSEcCtD
Hydralazine—P4HA1—liver—atherosclerosis	0.00393	0.0379	CbGeAlD
Hydralazine—Vascular purpura—Lovastatin—atherosclerosis	0.00388	0.00822	CcSEcCtD
Hydralazine—Haemolytic anaemia—Lovastatin—atherosclerosis	0.00385	0.00814	CcSEcCtD
Hydralazine—Hepatic function abnormal—Simvastatin—atherosclerosis	0.00372	0.00787	CcSEcCtD
Hydralazine—Vascular purpura—Simvastatin—atherosclerosis	0.00363	0.00769	CcSEcCtD
Hydralazine—Purpura—Lovastatin—atherosclerosis	0.00361	0.00763	CcSEcCtD
Hydralazine—Haemolytic anaemia—Simvastatin—atherosclerosis	0.0036	0.00762	CcSEcCtD
Hydralazine—Hepatic function abnormal—Niacin—atherosclerosis	0.00342	0.00723	CcSEcCtD
Hydralazine—Purpura—Simvastatin—atherosclerosis	0.00337	0.00714	CcSEcCtD
Hydralazine—Hepatic function abnormal—Pravastatin—atherosclerosis	0.00336	0.00711	CcSEcCtD
Hydralazine—Vascular purpura—Pravastatin—atherosclerosis	0.00329	0.00695	CcSEcCtD
Hydralazine—Haemolytic anaemia—Pravastatin—atherosclerosis	0.00326	0.00689	CcSEcCtD
Hydralazine—Renal failure acute—Pravastatin—atherosclerosis	0.00318	0.00673	CcSEcCtD
Hydralazine—Depression—Rosuvastatin—atherosclerosis	0.00315	0.00667	CcSEcCtD
Hydralazine—Cramp muscle—Lovastatin—atherosclerosis	0.00313	0.00662	CcSEcCtD
Hydralazine—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.0031	0.00655	CcSEcCtD
Hydralazine—Jaundice—Rosuvastatin—atherosclerosis	0.00308	0.00652	CcSEcCtD
Hydralazine—Cramp muscle—Ezetimibe—atherosclerosis	0.00307	0.00649	CcSEcCtD
Hydralazine—Purpura—Pravastatin—atherosclerosis	0.00305	0.00645	CcSEcCtD
Hydralazine—Haematuria—Rosuvastatin—atherosclerosis	0.00301	0.00637	CcSEcCtD
Hydralazine—Eosinophilia—Lovastatin—atherosclerosis	0.00297	0.00629	CcSEcCtD
Hydralazine—Cramp muscle—Simvastatin—atherosclerosis	0.00293	0.00619	CcSEcCtD
Hydralazine—Eosinophilia—Ezetimibe—atherosclerosis	0.00292	0.00617	CcSEcCtD
Hydralazine—RYR2—Stimuli-sensing channels—TRPV1—atherosclerosis	0.0029	0.0814	CbGpPWpGaD
Hydralazine—Urinary retention—Niacin—atherosclerosis	0.00284	0.006	CcSEcCtD
Hydralazine—Hepatitis—Rosuvastatin—atherosclerosis	0.00284	0.006	CcSEcCtD
Hydralazine—Eosinophilia—Simvastatin—atherosclerosis	0.00278	0.00589	CcSEcCtD
Hydralazine—Cramp muscle—Pravastatin—atherosclerosis	0.00265	0.0056	CcSEcCtD
Hydralazine—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00263	0.00555	CcSEcCtD
Hydralazine—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00257	0.00545	CcSEcCtD
Hydralazine—Jaundice—Ezetimibe—atherosclerosis	0.00256	0.00542	CcSEcCtD
Hydralazine—Eosinophilia—Pravastatin—atherosclerosis	0.00251	0.00532	CcSEcCtD
Hydralazine—Angina pectoris—Niacin—atherosclerosis	0.00251	0.00532	CcSEcCtD
Hydralazine—Depression—Simvastatin—atherosclerosis	0.0025	0.00528	CcSEcCtD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—GJA4—atherosclerosis	0.00249	0.0697	CbGpPWpGaD
Hydralazine—Angina pectoris—Pravastatin—atherosclerosis	0.00247	0.00523	CcSEcCtD
Hydralazine—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00246	0.0052	CcSEcCtD
Hydralazine—Jaundice—Simvastatin—atherosclerosis	0.00244	0.00517	CcSEcCtD
Hydralazine—Hepatitis—Lovastatin—atherosclerosis	0.0024	0.00509	CcSEcCtD
Hydralazine—Dysuria—Pravastatin—atherosclerosis	0.00238	0.00503	CcSEcCtD
Hydralazine—Hepatitis—Ezetimibe—atherosclerosis	0.00236	0.00499	CcSEcCtD
Hydralazine—Weight decreased—Pravastatin—atherosclerosis	0.0023	0.00486	CcSEcCtD
Hydralazine—Depression—Pravastatin—atherosclerosis	0.00226	0.00478	CcSEcCtD
Hydralazine—Hepatitis—Simvastatin—atherosclerosis	0.00225	0.00476	CcSEcCtD
Hydralazine—Jaundice—Niacin—atherosclerosis	0.00224	0.00474	CcSEcCtD
Hydralazine—Flushing—Lovastatin—atherosclerosis	0.00223	0.00472	CcSEcCtD
Hydralazine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00222	0.0047	CcSEcCtD
Hydralazine—Jaundice—Pravastatin—atherosclerosis	0.00221	0.00467	CcSEcCtD
Hydralazine—Flushing—Ezetimibe—atherosclerosis	0.00219	0.00463	CcSEcCtD
Hydralazine—Chills—Lovastatin—atherosclerosis	0.00216	0.00456	CcSEcCtD
Hydralazine—Arthralgia—Rosuvastatin—atherosclerosis	0.0021	0.00445	CcSEcCtD
Hydralazine—Myalgia—Rosuvastatin—atherosclerosis	0.0021	0.00445	CcSEcCtD
Hydralazine—Flushing—Simvastatin—atherosclerosis	0.00209	0.00442	CcSEcCtD
Hydralazine—Hepatitis—Niacin—atherosclerosis	0.00206	0.00437	CcSEcCtD
Hydralazine—Hypoaesthesia—Niacin—atherosclerosis	0.00205	0.00435	CcSEcCtD
Hydralazine—Hepatitis—Pravastatin—atherosclerosis	0.00203	0.0043	CcSEcCtD
Hydralazine—CYP3A4—Irinotecan Pathway—NPC1—atherosclerosis	0.00203	0.0568	CbGpPWpGaD
Hydralazine—Hypoaesthesia—Pravastatin—atherosclerosis	0.00202	0.00428	CcSEcCtD
Hydralazine—Chills—Simvastatin—atherosclerosis	0.00202	0.00427	CcSEcCtD
Hydralazine—Muscle spasms—Lovastatin—atherosclerosis	0.00201	0.00426	CcSEcCtD
Hydralazine—Muscle spasms—Ezetimibe—atherosclerosis	0.00197	0.00418	CcSEcCtD
Hydralazine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00197	0.00418	CcSEcCtD
Hydralazine—Tremor—Lovastatin—atherosclerosis	0.00196	0.00415	CcSEcCtD
Hydralazine—Ill-defined disorder—Lovastatin—atherosclerosis	0.00194	0.00411	CcSEcCtD
Hydralazine—Flushing—Niacin—atherosclerosis	0.00192	0.00405	CcSEcCtD
Hydralazine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.0019	0.00403	CcSEcCtD
Hydralazine—Anaemia—Ezetimibe—atherosclerosis	0.0019	0.00401	CcSEcCtD
Hydralazine—RYR2—Ion channel transport—TRPV1—atherosclerosis	0.00189	0.0531	CbGpPWpGaD
Hydralazine—Malaise—Lovastatin—atherosclerosis	0.00189	0.00399	CcSEcCtD
Hydralazine—Flushing—Pravastatin—atherosclerosis	0.00189	0.00399	CcSEcCtD
Hydralazine—Muscle spasms—Simvastatin—atherosclerosis	0.00188	0.00398	CcSEcCtD
Hydralazine—Leukopenia—Lovastatin—atherosclerosis	0.00187	0.00396	CcSEcCtD
Hydralazine—Chills—Niacin—atherosclerosis	0.00185	0.00392	CcSEcCtD
Hydralazine—Malaise—Ezetimibe—atherosclerosis	0.00185	0.00392	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00184	0.00388	CcSEcCtD
Hydralazine—Tremor—Simvastatin—atherosclerosis	0.00183	0.00388	CcSEcCtD
Hydralazine—Chills—Pravastatin—atherosclerosis	0.00182	0.00386	CcSEcCtD
Hydralazine—Ill-defined disorder—Simvastatin—atherosclerosis	0.00182	0.00384	CcSEcCtD
Hydralazine—Palpitations—Ezetimibe—atherosclerosis	0.00181	0.00384	CcSEcCtD
Hydralazine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00181	0.00383	CcSEcCtD
Hydralazine—Anaemia—Simvastatin—atherosclerosis	0.00181	0.00383	CcSEcCtD
Hydralazine—Myalgia—Lovastatin—atherosclerosis	0.00178	0.00377	CcSEcCtD
Hydralazine—Arthralgia—Lovastatin—atherosclerosis	0.00178	0.00377	CcSEcCtD
Hydralazine—Anxiety—Lovastatin—atherosclerosis	0.00178	0.00376	CcSEcCtD
Hydralazine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00177	0.00375	CcSEcCtD
Hydralazine—Malaise—Simvastatin—atherosclerosis	0.00177	0.00373	CcSEcCtD
Hydralazine—Discomfort—Lovastatin—atherosclerosis	0.00176	0.00372	CcSEcCtD
Hydralazine—Leukopenia—Simvastatin—atherosclerosis	0.00175	0.00371	CcSEcCtD
Hydralazine—Arthralgia—Ezetimibe—atherosclerosis	0.00175	0.0037	CcSEcCtD
Hydralazine—Myalgia—Ezetimibe—atherosclerosis	0.00175	0.0037	CcSEcCtD
Hydralazine—Muscle spasms—Niacin—atherosclerosis	0.00173	0.00366	CcSEcCtD
Hydralazine—Discomfort—Ezetimibe—atherosclerosis	0.00173	0.00365	CcSEcCtD
Hydralazine—Constipation—Rosuvastatin—atherosclerosis	0.00172	0.00365	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—HSPD1—atherosclerosis	0.00171	0.0478	CbGpPWpGaD
Hydralazine—Muscle spasms—Pravastatin—atherosclerosis	0.0017	0.0036	CcSEcCtD
Hydralazine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00167	0.00354	CcSEcCtD
Hydralazine—Arthralgia—Simvastatin—atherosclerosis	0.00167	0.00353	CcSEcCtD
Hydralazine—Myalgia—Simvastatin—atherosclerosis	0.00167	0.00353	CcSEcCtD
Hydralazine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00166	0.00351	CcSEcCtD
Hydralazine—Anxiety—Simvastatin—atherosclerosis	0.00166	0.00351	CcSEcCtD
Hydralazine—Tremor—Pravastatin—atherosclerosis	0.00166	0.00351	CcSEcCtD
Hydralazine—Discomfort—Simvastatin—atherosclerosis	0.00165	0.00348	CcSEcCtD
Hydralazine—Ill-defined disorder—Pravastatin—atherosclerosis	0.00164	0.00347	CcSEcCtD
Hydralazine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00164	0.00347	CcSEcCtD
Hydralazine—Anaemia—Pravastatin—atherosclerosis	0.00164	0.00346	CcSEcCtD
Hydralazine—Anorexia—Lovastatin—atherosclerosis	0.00163	0.00344	CcSEcCtD
Hydralazine—Leukopenia—Niacin—atherosclerosis	0.00161	0.0034	CcSEcCtD
Hydralazine—Urticaria—Rosuvastatin—atherosclerosis	0.0016	0.00339	CcSEcCtD
Hydralazine—Oedema—Simvastatin—atherosclerosis	0.0016	0.00338	CcSEcCtD
Hydralazine—Malaise—Pravastatin—atherosclerosis	0.0016	0.00338	CcSEcCtD
Hydralazine—Palpitations—Niacin—atherosclerosis	0.00159	0.00336	CcSEcCtD
Hydralazine—Leukopenia—Pravastatin—atherosclerosis	0.00158	0.00335	CcSEcCtD
Hydralazine—Thrombocytopenia—Simvastatin—atherosclerosis	0.00156	0.00331	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00156	0.00329	CcSEcCtD
Hydralazine—Paraesthesia—Lovastatin—atherosclerosis	0.00153	0.00324	CcSEcCtD
Hydralazine—Arthralgia—Niacin—atherosclerosis	0.00153	0.00324	CcSEcCtD
Hydralazine—Myalgia—Niacin—atherosclerosis	0.00153	0.00324	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00153	0.00323	CcSEcCtD
Hydralazine—Anorexia—Simvastatin—atherosclerosis	0.00152	0.00322	CcSEcCtD
Hydralazine—Dyspnoea—Lovastatin—atherosclerosis	0.00152	0.00322	CcSEcCtD
Hydralazine—Arthralgia—Pravastatin—atherosclerosis	0.00151	0.00319	CcSEcCtD
Hydralazine—Myalgia—Pravastatin—atherosclerosis	0.00151	0.00319	CcSEcCtD
Hydralazine—Paraesthesia—Ezetimibe—atherosclerosis	0.0015	0.00318	CcSEcCtD
Hydralazine—Dyspepsia—Lovastatin—atherosclerosis	0.0015	0.00318	CcSEcCtD
Hydralazine—Anxiety—Pravastatin—atherosclerosis	0.0015	0.00318	CcSEcCtD
Hydralazine—Dyspnoea—Ezetimibe—atherosclerosis	0.00149	0.00316	CcSEcCtD
Hydralazine—Discomfort—Pravastatin—atherosclerosis	0.00149	0.00315	CcSEcCtD
Hydralazine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00148	0.00314	CcSEcCtD
Hydralazine—Decreased appetite—Lovastatin—atherosclerosis	0.00148	0.00314	CcSEcCtD
Hydralazine—Dyspepsia—Ezetimibe—atherosclerosis	0.00147	0.00312	CcSEcCtD
Hydralazine—Oedema—Niacin—atherosclerosis	0.00147	0.0031	CcSEcCtD
Hydralazine—Constipation—Lovastatin—atherosclerosis	0.00146	0.00309	CcSEcCtD
Hydralazine—Decreased appetite—Ezetimibe—atherosclerosis	0.00146	0.00308	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00146	0.00308	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00145	0.00306	CcSEcCtD
Hydralazine—Oedema—Pravastatin—atherosclerosis	0.00144	0.00306	CcSEcCtD
Hydralazine—Paraesthesia—Simvastatin—atherosclerosis	0.00143	0.00304	CcSEcCtD
Hydralazine—Constipation—Ezetimibe—atherosclerosis	0.00143	0.00303	CcSEcCtD
Hydralazine—Tachycardia—Niacin—atherosclerosis	0.00143	0.00303	CcSEcCtD
Hydralazine—Pruritus—Rosuvastatin—atherosclerosis	0.00143	0.00302	CcSEcCtD
Hydralazine—Dyspnoea—Simvastatin—atherosclerosis	0.00142	0.00301	CcSEcCtD
Hydralazine—Thrombocytopenia—Pravastatin—atherosclerosis	0.00141	0.00299	CcSEcCtD
Hydralazine—Feeling abnormal—Lovastatin—atherosclerosis	0.00141	0.00298	CcSEcCtD
Hydralazine—Dyspepsia—Simvastatin—atherosclerosis	0.00141	0.00298	CcSEcCtD
Hydralazine—Anorexia—Niacin—atherosclerosis	0.0014	0.00296	CcSEcCtD
Hydralazine—CYP3A4—Liver X Receptor Pathway—ABCG8—atherosclerosis	0.00139	0.0391	CbGpPWpGaD
Hydralazine—Decreased appetite—Simvastatin—atherosclerosis	0.00139	0.00294	CcSEcCtD
Hydralazine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00138	0.00292	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00138	0.00292	CcSEcCtD
Hydralazine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00138	0.00292	CcSEcCtD
Hydralazine—Anorexia—Pravastatin—atherosclerosis	0.00138	0.00291	CcSEcCtD
Hydralazine—Hypotension—Niacin—atherosclerosis	0.00137	0.0029	CcSEcCtD
Hydralazine—Constipation—Simvastatin—atherosclerosis	0.00137	0.00289	CcSEcCtD
Hydralazine—Urticaria—Lovastatin—atherosclerosis	0.00136	0.00287	CcSEcCtD
Hydralazine—Body temperature increased—Lovastatin—atherosclerosis	0.00135	0.00286	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00134	0.00283	CcSEcCtD
Hydralazine—Dizziness—Rosuvastatin—atherosclerosis	0.00133	0.00282	CcSEcCtD
Hydralazine—Urticaria—Ezetimibe—atherosclerosis	0.00133	0.00282	CcSEcCtD
Hydralazine—Body temperature increased—Ezetimibe—atherosclerosis	0.00132	0.0028	CcSEcCtD
Hydralazine—Paraesthesia—Niacin—atherosclerosis	0.00132	0.00279	CcSEcCtD
Hydralazine—Feeling abnormal—Simvastatin—atherosclerosis	0.00132	0.00279	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00132	0.00278	CcSEcCtD
Hydralazine—Dyspnoea—Niacin—atherosclerosis	0.00131	0.00277	CcSEcCtD
Hydralazine—Paraesthesia—Pravastatin—atherosclerosis	0.0013	0.00274	CcSEcCtD
Hydralazine—Dyspepsia—Niacin—atherosclerosis	0.00129	0.00273	CcSEcCtD
Hydralazine—Dyspnoea—Pravastatin—atherosclerosis	0.00129	0.00272	CcSEcCtD
Hydralazine—Decreased appetite—Niacin—atherosclerosis	0.00128	0.0027	CcSEcCtD
Hydralazine—Dyspepsia—Pravastatin—atherosclerosis	0.00127	0.00269	CcSEcCtD
Hydralazine—Rash—Rosuvastatin—atherosclerosis	0.00127	0.00269	CcSEcCtD
Hydralazine—Dermatitis—Rosuvastatin—atherosclerosis	0.00127	0.00269	CcSEcCtD
Hydralazine—Urticaria—Simvastatin—atherosclerosis	0.00127	0.00269	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Niacin—atherosclerosis	0.00127	0.00268	CcSEcCtD
Hydralazine—Body temperature increased—Simvastatin—atherosclerosis	0.00126	0.00267	CcSEcCtD
Hydralazine—Headache—Rosuvastatin—atherosclerosis	0.00126	0.00267	CcSEcCtD
Hydralazine—Hypersensitivity—Lovastatin—atherosclerosis	0.00126	0.00266	CcSEcCtD
Hydralazine—Decreased appetite—Pravastatin—atherosclerosis	0.00126	0.00266	CcSEcCtD
Hydralazine—Constipation—Pravastatin—atherosclerosis	0.00124	0.00261	CcSEcCtD
Hydralazine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00123	0.00261	CcSEcCtD
Hydralazine—Pruritus—Lovastatin—atherosclerosis	0.00121	0.00256	CcSEcCtD
Hydralazine—Nausea—Rosuvastatin—atherosclerosis	0.0012	0.00253	CcSEcCtD
Hydralazine—Feeling abnormal—Pravastatin—atherosclerosis	0.00119	0.00252	CcSEcCtD
Hydralazine—Pruritus—Ezetimibe—atherosclerosis	0.00119	0.00251	CcSEcCtD
Hydralazine—Hypersensitivity—Simvastatin—atherosclerosis	0.00118	0.00249	CcSEcCtD
Hydralazine—Diarrhoea—Lovastatin—atherosclerosis	0.00117	0.00247	CcSEcCtD
Hydralazine—Urticaria—Niacin—atherosclerosis	0.00117	0.00247	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.00116	0.0325	CbGpPWpGaD
Hydralazine—Body temperature increased—Niacin—atherosclerosis	0.00116	0.00245	CcSEcCtD
Hydralazine—Urticaria—Pravastatin—atherosclerosis	0.00115	0.00243	CcSEcCtD
Hydralazine—Diarrhoea—Ezetimibe—atherosclerosis	0.00115	0.00243	CcSEcCtD
Hydralazine—Body temperature increased—Pravastatin—atherosclerosis	0.00114	0.00242	CcSEcCtD
Hydralazine—Pruritus—Simvastatin—atherosclerosis	0.00113	0.00239	CcSEcCtD
Hydralazine—Dizziness—Lovastatin—atherosclerosis	0.00113	0.00239	CcSEcCtD
Hydralazine—Dizziness—Ezetimibe—atherosclerosis	0.00111	0.00234	CcSEcCtD
Hydralazine—Diarrhoea—Simvastatin—atherosclerosis	0.00109	0.00231	CcSEcCtD
Hydralazine—Vomiting—Lovastatin—atherosclerosis	0.00109	0.0023	CcSEcCtD
Hydralazine—Hypersensitivity—Niacin—atherosclerosis	0.00108	0.00229	CcSEcCtD
Hydralazine—Rash—Lovastatin—atherosclerosis	0.00108	0.00228	CcSEcCtD
Hydralazine—Dermatitis—Lovastatin—atherosclerosis	0.00108	0.00228	CcSEcCtD
Hydralazine—Headache—Lovastatin—atherosclerosis	0.00107	0.00226	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.00107	0.0299	CbGpPWpGaD
Hydralazine—Vomiting—Ezetimibe—atherosclerosis	0.00107	0.00225	CcSEcCtD
Hydralazine—Hypersensitivity—Pravastatin—atherosclerosis	0.00106	0.00225	CcSEcCtD
Hydralazine—Dizziness—Simvastatin—atherosclerosis	0.00106	0.00224	CcSEcCtD
Hydralazine—Rash—Ezetimibe—atherosclerosis	0.00106	0.00223	CcSEcCtD
Hydralazine—Dermatitis—Ezetimibe—atherosclerosis	0.00106	0.00223	CcSEcCtD
Hydralazine—Headache—Ezetimibe—atherosclerosis	0.00105	0.00222	CcSEcCtD
Hydralazine—CYP3A4—liver—atherosclerosis	0.00104	0.0101	CbGeAlD
Hydralazine—Pruritus—Niacin—atherosclerosis	0.00104	0.0022	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.00102	0.0287	CbGpPWpGaD
Hydralazine—Pruritus—Pravastatin—atherosclerosis	0.00102	0.00216	CcSEcCtD
Hydralazine—Vomiting—Simvastatin—atherosclerosis	0.00102	0.00215	CcSEcCtD
Hydralazine—Nausea—Lovastatin—atherosclerosis	0.00101	0.00215	CcSEcCtD
Hydralazine—Rash—Simvastatin—atherosclerosis	0.00101	0.00213	CcSEcCtD
Hydralazine—Dermatitis—Simvastatin—atherosclerosis	0.00101	0.00213	CcSEcCtD
Hydralazine—Diarrhoea—Niacin—atherosclerosis	0.001	0.00212	CcSEcCtD
Hydralazine—Headache—Simvastatin—atherosclerosis	0.001	0.00212	CcSEcCtD
Hydralazine—CYP3A4—Liver X Receptor Pathway—CYP7A1—atherosclerosis	0.000999	0.028	CbGpPWpGaD
Hydralazine—Nausea—Ezetimibe—atherosclerosis	0.000995	0.00211	CcSEcCtD
Hydralazine—Diarrhoea—Pravastatin—atherosclerosis	0.000988	0.00209	CcSEcCtD
Hydralazine—Dizziness—Niacin—atherosclerosis	0.00097	0.00205	CcSEcCtD
Hydralazine—Dizziness—Pravastatin—atherosclerosis	0.000955	0.00202	CcSEcCtD
Hydralazine—Nausea—Simvastatin—atherosclerosis	0.000949	0.00201	CcSEcCtD
Hydralazine—Vomiting—Niacin—atherosclerosis	0.000933	0.00197	CcSEcCtD
Hydralazine—Rash—Niacin—atherosclerosis	0.000925	0.00196	CcSEcCtD
Hydralazine—Dermatitis—Niacin—atherosclerosis	0.000924	0.00196	CcSEcCtD
Hydralazine—Headache—Niacin—atherosclerosis	0.000919	0.00194	CcSEcCtD
Hydralazine—Vomiting—Pravastatin—atherosclerosis	0.000918	0.00194	CcSEcCtD
Hydralazine—Rash—Pravastatin—atherosclerosis	0.000911	0.00193	CcSEcCtD
Hydralazine—Dermatitis—Pravastatin—atherosclerosis	0.00091	0.00193	CcSEcCtD
Hydralazine—Headache—Pravastatin—atherosclerosis	0.000905	0.00191	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.000897	0.0251	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—PRKCG—atherosclerosis	0.000888	0.0249	CbGpPWpGaD
Hydralazine—Nausea—Niacin—atherosclerosis	0.000871	0.00184	CcSEcCtD
Hydralazine—CYP3A4—Liver X Receptor Pathway—ABCG5—atherosclerosis	0.000865	0.0242	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—PRKCG—atherosclerosis	0.00086	0.0241	CbGpPWpGaD
Hydralazine—Nausea—Pravastatin—atherosclerosis	0.000858	0.00182	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000809	0.0227	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000733	0.0206	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.00066	0.0185	CbGpPWpGaD
Hydralazine—CYP3A4—Drug Induction of Bile Acid Pathway—CYP7A1—atherosclerosis	0.000654	0.0183	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000635	0.0178	CbGpPWpGaD
Hydralazine—CYP3A4—Farnesoid X Receptor  Pathway—CYP7A1—atherosclerosis	0.000598	0.0168	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—NOS3—atherosclerosis	0.000556	0.0156	CbGpPWpGaD
Hydralazine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—atherosclerosis	0.000549	0.0154	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.00049	0.0137	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IL1B—atherosclerosis	0.000473	0.0132	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.00047	0.0132	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—CETP—atherosclerosis	0.00047	0.0132	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—NFKB1—atherosclerosis	0.000441	0.0124	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000439	0.0123	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000414	0.0116	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000414	0.0116	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000398	0.0112	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000375	0.0105	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000352	0.00987	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000341	0.00956	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000325	0.00911	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000325	0.00911	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000311	0.00872	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IL6—atherosclerosis	0.000277	0.00776	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000275	0.00772	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.000263	0.00736	CbGpPWpGaD
Hydralazine—CYP3A4—Estrogen metabolism—GSTM1—atherosclerosis	0.000258	0.00722	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000246	0.0069	CbGpPWpGaD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.000238	0.00668	CbGpPWpGaD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000235	0.00659	CbGpPWpGaD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.00022	0.00617	CbGpPWpGaD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.000217	0.00609	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000195	0.00547	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000194	0.00543	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000193	0.00541	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000179	0.005	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000134	0.00377	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000111	0.00311	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	0.000103	0.00288	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000101	0.00284	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	9.49e-05	0.00266	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	9.36e-05	0.00262	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	4.24e-05	0.00119	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	4.18e-05	0.00117	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	3e-05	0.000842	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PLTP—atherosclerosis	2.82e-05	0.000791	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.45e-05	0.000686	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.45e-05	0.000686	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.94e-05	0.000542	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.82e-05	0.00051	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.82e-05	0.00051	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.79e-05	0.000501	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.75e-05	0.000492	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.62e-05	0.000455	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.54e-05	0.000431	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.54e-05	0.000431	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.54e-05	0.000431	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOA2—atherosclerosis	1.54e-05	0.000431	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.52e-05	0.000426	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LPA—atherosclerosis	1.47e-05	0.000411	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—BGN—atherosclerosis	1.42e-05	0.000398	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOA5—atherosclerosis	1.41e-05	0.000394	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.35e-05	0.000379	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.31e-05	0.000366	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.17e-05	0.000329	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LIPC—atherosclerosis	1.17e-05	0.000327	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOC3—atherosclerosis	1.16e-05	0.000325	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LDLR—atherosclerosis	1.15e-05	0.000323	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CETP—atherosclerosis	1.12e-05	0.000315	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.08e-05	0.000302	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.02e-05	0.000285	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ABCA1—atherosclerosis	9.06e-06	0.000254	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HMOX1—atherosclerosis	7.78e-06	0.000218	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOB—atherosclerosis	7.45e-06	0.000209	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GSTM1—atherosclerosis	7.25e-06	0.000203	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LPL—atherosclerosis	7.11e-06	0.000199	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GPX1—atherosclerosis	6.94e-06	0.000194	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CD36—atherosclerosis	6.76e-06	0.000189	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—MTHFR—atherosclerosis	6.4e-06	0.000179	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPARA—atherosclerosis	6.28e-06	0.000176	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AGT—atherosclerosis	6.08e-06	0.000171	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOE—atherosclerosis	5.96e-06	0.000167	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CAV1—atherosclerosis	5.91e-06	0.000166	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOA1—atherosclerosis	5.89e-06	0.000165	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	5.38e-06	0.000151	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPARG—atherosclerosis	5.19e-06	0.000146	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—INS—atherosclerosis	5.09e-06	0.000143	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALB—atherosclerosis	4.67e-06	0.000131	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NOS3—atherosclerosis	4.47e-06	0.000125	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.08e-06	0.000114	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AKT1—atherosclerosis	2.05e-06	5.75e-05	CbGpPWpGaD
